04:16 PM EST, 02/11/2025 (MT Newswires) -- Gilead Sciences ( GILD ) reported Q4 non-GAAP earnings late Tuesday of $1.90 per diluted share, up from $1.72 a year earlier.

Analysts polled by FactSet expected $1.74.

Revenue for the quarter ended Dec. 31 was $7.57 billion, up from $7.12 billion a year earlier.

Analysts surveyed by FactSet expected $7.15 billion.

The company said it expects 2025 non-GAAP diluted EPS between $7.70 and $8.10.

Analysts polled by FactSet expect $7.61.

Shares of Gilead Sciences ( GILD ) were up 4% in after-hours activity.